C6 NBD Galactosylceramide (d18:1/6:0)

C6 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C6 nitrobenzoxadiazole (C6 NBD, Cay-18871) group. C6 NBD galactosylceramide has been used to study intracellular localization and metabolism of galactosylceramide, a sphingolipid whose synthesis is disrupted in Krabbe disease due to a deficiency of galactosylceramide beta-galactosidase. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1621]Formal Name: N-[(1S,2R,3E)-1-[(beta-D-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide. CAS Number: 170212-26-7. Synonyms: N-hexanoyl-NBD-Galactosylceramide, C6 NBD Galactosylceramide, NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer, NBD GalCer(d18:1/6:0). Molecular Formula: C36H59N5O11. Formula Weight: 737.9. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: Chloroform:Methanol (5:1): soluble, Methanol: soluble. SMILES: CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(CCCCCNC1=CC=C([N+]([O-])=O)C2=NON=C12)=O)CO[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O. InChi Code: InChI=1S/C36H59N5O11/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-28(43)26(24-50-36-35(47)34(46)33(45)29(23-42)51-36)38-30(44)19-16-14-17-22-37-25-20-21-27(41(48)49)32-31(25)39-52-40-32/h15,18,20-21,26,28-29,33-37,42-43,45-47H,2-14,16-17,19,22-24H2,1H3,(H,38,44)/b18-15+/t26-,28+,29+,33-,34-,35+,36+/m0/s1. InChi Key: ZYEQNDHFYIPTAY-LFUFHFQKSA-N.